Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC11549705 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature